Klonidin (When ATH C02AC01)

When ATH:
C02AC01

Characteristic.

The white crystalline powder. Soluble in water, poorly soluble in alcohol, chloroform and ether.

Pharmacological action.
Gipotenzivnoe, sedation.

Application.

Hypertensive crises, arterial hypertension, myocardial infarction in the acute phase (in the absence of cardiogenic shock and the concomitant increase in blood pressure), Primary open-angle glaucoma with high and medium level of intraocular pressure, opium addiction withdrawal (in the complex therapy).

Contraindications.

Hypersensitivity, cardiogenic shock, hypotension, obliterating peripheral arterial disease, AV block II-III degrees, sick sinus syndrome, depression.

Restrictions apply.

Pregnancy, lactation; Job, related to the need quick mental or physical reaction.

Pregnancy and breast-feeding.

Category actions result in FDA - C. (The study of reproduction in animals has revealed adverse effects on the fetus, and adequate and well-controlled studies in pregnant women have not held, However, the potential benefits, associated with drugs in pregnant, may justify its use, in spite of the possible risk.)

Side effects.

Dry mouth, constipation, weakness, drowsiness.

Cooperation.

The hypotensive effect weakens Nifedipine. When applied with neuroleptics are synergies of sedation, can be expressed depressive disorders.

Overdose.

Symptoms: disturbance of consciousness, collapse, for the state of acute poisoning is aetiology, уширение комплекса QRS, may slow AV conduction syndrome early repolarization.

Treatment: symptomatic.

Dosing and Administration.

Inside, parenterally, instillation in eye (drops). The dosage and treatment regimen individual.